Taro Pharmaceutical Industries Ltd. (TAL.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 08:08AM CEST. Market open.
| Previous close | 39.60 |
| Open | 39.80 |
| Bid | 39.80 x 20000 |
| Ask | 40.00 x 20000 |
| Day's range | 39.80 - 39.80 |
| 52-week range | 30.80 - 39.80 |
| Volume | |
| Avg. volume | 1 |
| Market cap | 1.503B |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | 29.92 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 10 Dec 2018 |
| 1y target est | N/A |
- PR Newswire
Taro Shareholders Approve Merger with Sun Pharma
Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associates referred as "Sun Pharma") and Taro Pharmaceutical Industries Ltd. (NYSE: TARO) ("Taro" or the "Company") today announced that the merger agreement between Taro and Sun Pharma was approved by the affirmative vote of Taro shareholders (including a vote of the majority of shares held by Taro shareholders unaffiliated with Sun Pharma) at an Extrao
- Business Wire
Taro Provides Results for Year Ended March 31, 2024
HAWTHORNE, N.Y., May 20, 2024--TARO PROVIDES RESULTS FOR YEAR ENDED MARCH 31, 2024
- Business Wire
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
NEW YORK, May 08, 2024--Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
© 2024 Yahoo. All rights reserved.